Cardiome Pharma Corp. (CRME) Posts Q1 Loss of 20c/Share

Cardiome Pharma Corp. (NASDAQ: CRME) reported Q1 EPS of ($0.20), $0.09 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $7.6 million versus the consensus estimate of $8.08 million.

For earnings history and earnings-related data on Cardiome Pharma Corp. (CRME) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Cisco rating cut at HSBC as analyst sees a lack of catalysts
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15